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Abstract: The marine environment is home to a taxonomically diverse ecosystem. Organisms such
as algae, molluscs, sponges, corals, and tunicates have evolved to survive the high concentrations
of infectious and surface-fouling bacteria that are indigenous to ocean waters. Both macroalgae
(seaweeds) and microalgae (diatoms) contain pharmacologically active compounds such as
phlorotannins, fatty acids, polysaccharides, peptides, and terpenes which combat bacterial invasion.
The resistance of pathogenic bacteria to existing antibiotics has become a global epidemic. Marine
algae derivatives have shown promise as candidates in novel, antibacterial drug discovery. The
efficacy of these compounds, their mechanism of action, applications as antibiotics, disinfectants, and
inhibitors of foodborne pathogenic and spoilage bacteria are reviewed in this article.
Keywords: marine antibacterial; seaweeds; micro-algae; nutraceuticals; antibiotic-resistance;
food preservation; disinfectants; allelopathy
1. Introduction
The search for bioactive compounds from marine organisms in recent decades has produced
an abundance of extracts with pharmaceutical and industrial applications. In 2013 alone, over
one thousand pharmacologically active compounds of marine origin were characterised worldwide,
with potential efficacy against cancer, viruses, bacteria, fungi, hypertension, high cholesterol and
other diseases. Marine organisms commonly targeted for screening include macro and microalgae,
cnidarians, phytoplankton, molluscs, sponges, corals, tunicates, and bryozoans. Much of this
research has concerned the identification of antimicrobial agents; particularly compounds active
against pathogenic bacteria [1,2]. The global epidemic of bacterial resistance to existing antibiotics
such as β-lactams and quinolones has prompted the search for naturally occurring candidate
drugs, anti-fouling agents, and food preservation agents from terrestrial and marine sources. The
evolution of antibacterial biomolecules alongside bacteria over millions of years may provide them
with the potential to overcome strains such as methicillin resistant Staphylococcus aureus (MRSA)
and fluoroquinolone-resistant Pseudomonas [3]. Antibacterials from the marine environment in
particular have been studied. Micro and macroalgae, such as diatoms and seaweeds, have developed
indigenous systems to combat pathogenic bacteria and other microbes, ubiquitous to the ocean
environment. This review focuses on antibacterial compounds derived from marine algae, their
mechanism of pharmacological action, and outlines their current and potential applications as
antibiotics, disinfectants, and inhibitors of foodborne pathogenic and spoilage bacteria.
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2. Antibacterial Compounds in Marine Algae and Their Functional Groups
Algae have traditionally been used as food, or for hydrocolloids such as alginate and carrageenan.
However, modern screening methods have identified antibacterial compounds in the secondary
metabolites of algal classes such as the Phaeophyceae (brown), Rhodophyceae (red), Chlorophyceae
(green), Chrysophyceae (golden) and Bacillariophyceae (diatoms) [4–8]. Functional groups with
antibacterial activity in these compounds include phlorotannins, fatty acids, polysaccharides, peptides,
terpenes, polyacetylenes, sterols, indole alkaloids, aromatic organic acids, shikimic acid, polyketides,
hydroquinones, alcohols, aldehydes, ketones, and halogenated furanones, alkanes, and alkenes [9–11].
The ecological function of some of these secondary metabolites in algae is not yet fully understood.
Since they are not required for normal growth or reproduction, adaption to conditions to which they
are exposed in the ocean is proposed to be the main factor controlling their occurrence. Impediments
to algal survival include grazing by herbivores, competition for space from other organisms, thallus
injury, and biofilm formation. Algae are also exposed to osmotic stress; and high levels of UV light,
oxygen, and salinity. In addition, an average of one million bacterial cells are present in each millilitre
of seawater [12]. Some of the chemicals produced by algae to combat these stresses have antibacterial
potential, and many have high biological activity due to the diluting effect of seawater and the harsh
environment in which they live [13].
Algal Allelopathy
The biological phenomenon of allelopathy in terrestrial and marine habitats contributes to the
production of potentially antibacterial compounds. Allelochemicals are released by many algae into
their environment. These secondary metabolites exert beneficial or detrimental effects on competing
organisms, the end result of which offers a competitive advantage to the alga. Sessile algae such as
seaweeds are more prone to bacterial biofilm formation and consumption by invertebrates compared
to motile, single cell algae. Allelochemicals have been identified in several species which aid algae in
competition for anchoring space on rocks and the seabed. Many of these compounds are toxic, with
applications in cancer chemotherapy, and are currently being screened for antibacterial potential [14].
Vieira et al. [15] characterised three new lobophorenols (C21 polyunsaturated alcohols) in
the brown seaweed genus, Lobophora, which had significant allelopathic effects against the coral,
Acropora muricata, causing bleaching and necrosis. Similarly, two acetylated diterpenes reported by
Rasher et al. [16] in the green alga, Chlorodesmis fastigiata, and two loliolide derivatives from the red alga,
Galaxaura filamentosa, acted as potent allelochemicals against corals. The lipophilic compounds were
secreted from thallus surfaces and inhibited photosynthesis in the corals, causing bleaching, and in
some cases, death. A kainic acid analogue, domoic acid, produced by the diatom genus, Pseudo-nitzschia,
acts as an intra and inter-species allelochemical, and is responsible for toxic algal blooms. Domoic
acid is an excitotoxic amino acid that affects the central nervous system in vertebrates such as shrimp,
and competitively inhibits the growth of other Pseudo-nitzschia species [17,18]. Similarly, ovatoxins
and palytoxins produced by the toxic dinoflagellate protozoan, Ostreopsis, [19] act as allelochemical
deterrents to neighbouring vertebrates, and can cause algal blooms. Accoroni et al. [20] examined
the allelopathic interactions between Ostreopsis cf. ovata and three seaweeds, Dictyota dichotoma,
Rhodymenia pseudopalmata, and Ulva rigida that compete for space in the same habitat. Fresh and dried
thalli of Dictyota dichotoma and Rhodymenia pseudopalmata were found to significantly inhibit the growth
of Ostreopsis ovata. The compounds responsible are currently being elucidated and have potential
applications in the prevention of algal blooms, and as antibacterials.
Phlorotannins and terpenes in algae also act as allelochemical deterrents to herbivores, inhibitors
of bacterial biofilm formation, and as antioxidants against UV damage [21–23]. Phlorotannins are
composed of polyphenolic phloroglucinol units and occur in Phaeophyceae. They have the ability to
bind with and precipitate proteins in the same way tannins do in terrestrial plants. This makes the
algae more astringent and less palatable to grazers as it binds with proteins in the mouth [24–26].
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Some seaweeds, such as the green alga, Caulerpa cylindracea, have developed immunity to
several pathogenic epiphytic Vibrio species that live on their thallus surface. A symbiotic allelopathic
relationship with the bacteria has been proposed by Rizzo et al. [7], where the presence of the Vibrio
actually contributes to successful algal reproduction, allowing the two organisms to function as a
holobiont [27]. Foodborne illness caused by Vibrio and other pathogenic bacteria is an increasing global
issue. Isolation of the compounds and the mechanism responsible for algal immunity to these bacteria
could produce useful therapeutics and sanitisers. The harnessing and bioengineering of recently
characterised allelochemicals represents a potential area of new marine antibacterials.
3. Mechanisms of Pharmacological Action and Potential Applications
Bactericidal and bacteriostatic compounds were first isolated from algae when chloroform
and benzene fatty acid extracts of chlorellin, from Chlorella vulgaris, were found to inhibit
Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pyogenes, and Bacillus subtilis [28]. Chlorellin
was not suitable for large scale commercial use, however it heralded further research into algal
antimicrobial inhibitors in genera such as Scenedesmus [29]. As discussed, several chemical functional
groups in algae, such as phlorotannins, fatty acids, peptides, terpenes, polysaccharides, polyacetylenes,
sterols, indole alkaloids, aromatic organic acids, shikimic acid, polyketides, hydroquinones, alcohols,
aldehydes, ketones, and halogenated furanones have been reported as bacterial inhibitors. The
mechanism of pharmacological action for some remains uncertain, however, methods of bacterial
inhibition employed by the following functional groups have been proposed.
3.1. Phlorotannins
Phlorotannins occur in fucosan granules called physodes within algal cells and comprise 1%–15%
of the thallus dry mass [30]. The antibacterial activity of phlorotannins has been reported to be due
to inhibition of oxidative phosphorylation, and their ability to bind with bacterial proteins such as
enzymes and cell membranes, causing cell lysis. The phenolic aromatic rings and OH groups of
the phloroglucinol units bind to the -NH groups of bacterial proteins by H-bond and hydrophobic
interactions [31,32]. Kamei and Isnansetyo [33] reported that the bacteriolytic activity of phloroglucinol
compounds against Vibrio species increased when tertiary structures such as methyl- or acetyl-vinyl
were present. However, a greater minimum inhibitory concentration (MIC) was required to penetrate
the Gram-negative species, Vibrio parahaemolyticus, compared to the Gram-positive MRSA. This is the
case for most antibacterials, due to physiological differences in β-lactamase mechanisms, and the less
penetrable nature of the outer lipopolysaccharide membrane of Gram-negative species in comparison
to the peptidoglycan Gram-positive layer [34].
Wei et al. [35] reported that low molecular weight phlorotannins extracted from
Sargassum thunbergii damaged the cell membrane and cell wall of Vibrio parahaemolyticus, causing
cytoplasm leakage and deconstruction of membrane permeability. The study suggested that low
molecular weight phlorotannins from algae could potentially be used in food safety control and
aquacultural drugs. Lee et al. [36] tested a range of solvent extracts from the brown seaweed, Arame
(Eisenia bicyclis) against antibiotic resistant Propionibacterium-related acne. A phlorofucofuroeckol
compound (phlorotannin with an alcohol substituent) exhibited the most potent antibacterial activity
with an MIC of 32 µg/mL, while also significantly reversing the resistance of Propionibacterium to
erythromycin and lincomycin. The same research group tested the activity of phlorofucofuroeckol
from Eisenia bicyclis against MRSA. Phlorofucofuroeckol suppressed mecI, mecR1, and mecA gene
expression in the resistant Staphylococcus aureus cells. These three genes regulate the expression
of methicillin resistance in bacteria. This resulted in suppression of penicillin-binding protein 2a
production, which is considered the main mechanism by which MRSA strains resist methicillin [37,38].
Phlorotannins and their derivatives offer a potentially useful source of natural antibacterial agents for
food and medical applications.
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3.2. Fatty Acids
Algal free fatty acids have been reported to act as inhibitors of the electron transport
chain and normal oxidative phosphorylation in bacterial cell membranes. This interferes
with adenosine triphosphate energy transfer, and inhibits enzymes such as bacterial enoyl-acyl
carrier protein reductase, necessary for the synthesis of fatty acids within the bacterial cell.
Lysis of the cell, and formation of peroxidation and auto-oxidation degradation products then
occurs [39–42]. El Shafay et al. [43] identified the antibacterial fatty acids, cyclopentaneacetic acid,
and 10,13-octadeadienoic acid as principal components of ethanol extracted Sargassum vulgare and
diethyl ether extracted Sargassum fusiforme. Transmission electron microscopy was used to measure
the morphological changes in Staphylococcus aureus and Klebsiella pneumoniae cells treated with these
brown seaweed extracts. The cell walls of both bacteria were perforated, resulting in rupture of the
cell wall, cytoplasmic leakage, shrinking of the protoplasm, cytoplasmic vacuolation, scattering of
chromatin, distortion of the outer cell shape, and decreased cell size. Cˇermák et al. [44] reported the
antibacterial long-chain fatty acids in the green microalga Planktochlorella nurekis to be significant
inhibitors of Campylobacter jejuni, Escherichia coli, Salmonella enterica var. Enteritidis, Salmonella enterica
var. Infantis, Arcobacter butzleri, and Lactobacillus johnsonii using a suspension concentration range of
0.75–6 mg/mL. The study proposed that green microalgae could be used as an alternative to in-feed
antibiotics to prevent disease in livestock and poultry and to maintain the microbial safety of animal
products in the human food chain.
3.3. Polysaccharides
Polysaccharides are composed of repeating monosaccharide units linked by glycosidic bonds.
They function primarily as structural storage compounds in plants and algae. Algal polysaccharides
and sulphated polysaccharides have been used successfully for pharmaceutical and dietary
applications. Their mechanism of antibacterial action is proposed to be due to glycoprotein-receptors
present on the cell-surface of polysaccharides which bind with compounds in the bacterial cell wall,
cytoplasmic membrane, and DNA. This results in increased permeability of the cytoplasmic membrane,
protein leakage, and binding of bacterial DNA [45–47]. Polysaccharides, such as fucoidan and
laminarin, have been successfully used in drug delivery as oral antibiotics to inhibit the growth
of Staphylococcus aureus and Escherichia coli; and to prevent the adhesion of Helicobacter pylori biofilms
in gastric mucosa. They have also been incorporated into food as a dietary supplement to improve the
immune response of farmed fish, and reduce susceptibility to Piscirickettsia salmonis infection [48–51].
Kadam et al. [48] reported a significant inhibition of Staphylococcus aureus, Listeria monocytogenes,
Escherichia coli and Salmonella typhimurium growth with ultrasound assisted extraction of laminarin
from the Irish brown seaweeds Ascophyllum nodosum and Laminaria hyperborea using 0.1 M hydrochloric
acid. Abou Zeid et al. [52] demonstrated that hot and cold water-extracted polysaccharides from the
red seaweed Pterocladia capillacea and brown seaweed Dictyopteris membranacea inhibit the growth of
Gram-positive Bacillus cereus and Staphylococcus aureus, and Gram-negative Pseudomonas fluorescens and
Escherichia coli in disc diffusion assays. In the case of Staphylococcus aureus, cold water-extracted
Pterocladia capillacea had an activity equivalent to 56.8% of the antibiotic standard, ampicillin.
Vijayabaskar et al. [53] found that sulphated polysaccharides extracted from Sargassum swartzii inhibited
both Gram-positive and Gram-negative bacteria in ten human pathogenic strains. In the case of
Escherichia coli, the polysaccharide extract was more potent in the disc diffusion assay than an ampicillin
antibiotic standard.
3.4. Proteins and Peptides
The antimicrobial activity of amino acids in the form of short-chain peptides, or larger, more
complex proteins, has been demonstrated in a number of recent studies. The amphipathic conformation
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of peptides enables them to bind with polar and non-polar sites on bacterial cytoplasmic membranes,
thereby interfering with cellular processes and propagation [54–56].
Lectins, for example, are a diverse group of proteins that occur in animals, plants, algae, bacteria,
and viruses [57]. In humans, they have multiple biological functions including carbohydrate-binding,
cell adhesion, blood-protein regulation, and immune defence [58]. The ability of lectins to selectively
bind with lipopolysaccharides, β-glucans, and peptidoglycans on the cell surface of bacteria affords
them bactericidal properties, as normal cell processes such as nutrient uptake are blocked [59]. Several
functional groups are involved. Hydrogen bonds are formed between polar moieties of amino acids in
the lectins and the hydroxyl groups of polysaccharides, coupled with van der Waals interactions,
and packing of hydrophobic polysaccharide regions against amino acid aromatic groups in the
lectins [60–62]. Holanda et al. [63] evaluated the inhibitory effect of lectin extracts from the red alga
Solieria filiformis against Gram-negative and Gram-positive pathogenic bacteria. At a concentration
of 1000 µg/mL, the extract inhibited growth of the Gram-negative species Pseudomonas aeruginosa,
Enterobacter aerogenes, Serratia marcescens, Salmonella typhi, Klebsiella pneumoniae, and Proteus species.
The binding of lectin with mannan was believed to be the method by which growth was inhibited.
Mannan is a linear polymer of the saccharide monomer mannose, and occurs on the cell surface of
Gram-negative bacteria. Mannan acts as a hapten upon binding with the large lectin molecule, eliciting
an immune response. However, no inhibition of growth was observed against the Gram-positive
Staphylococcus aureus and Bacillus subtilis, possibly due to unsuitable lectin-polysaccharide binding
sites on the cell surfaces of these species [64].
Enzymatic hydrolysis is the most common method used to isolate bioactive peptides from parent
proteins for medical applications, thus avoiding toxic solvent residues. The bioactivity of individual
peptide hydrolysates is often distinct from, or greater than that of the original protein. Some recently
characterised peptides have been termed crypteins, due to their cryptic, or hidden, bioactivity, and
are a current area of novel therapeutic study [65]. Marine algae are good candidates for the mining of
such peptides as they contain a high proportion of diverse proteins [66,67].
Beaulieu et al. [68] extracted antibacterial peptides (>10 kDa mass) from the brown seaweed
Saccharina longicruris by enzymatic hydrolysis with trypsin. Liquid chromatography-tandem mass
spectrometry identified the sub-fractions as peptide precursors to proteins similar to ubiquitin, leucine,
histone, and a ribosomal structure, which form part of the innate immune defence of the seaweed.
Maximum specific growth rate of the food spoilage bacterium Staphylococcus aureus was significantly
inhibited by the hydrolysate at concentrations of 0.31 mg/mL to 2.5 mg/mL making it a potential
agent for food preservation.
3.5. Terpenes
Terpenes are compounds composed of repeating isoprene units, often with substituent groups.
Terpenes with pharmacological activity have been successfully extracted from terrestrial plants.
For example, paclitaxel (or taxol) from Pacific yew trees is used in cancer treatment, and Artemisinin
from the plant Artemisia annua is an anti-malarial drug [69,70]. A number of terpene compounds
from algae, such as diterpene-benzoate bromophycolides, have been found to inhibit bacterial
growth. Lane et al. [71] extracted bromophycolides (diterpene-benzoate macrolides) from the Fijian
red alga Callophycus serratus with water, methanol, and dichloromethane. Extracts significantly
inhibited MRSA and vancomycin-resistant Enterococcus faecium, with maximal inhibitory concentration
(IC50) values of 1.4 µM and 5.8 µM respectively. Their findings suggested that the mechanism of
antibacterial action was due to the hydrophobicity and conformational rigidity of the tetrahydropyran
structure. Rodrigues et al. [72] used dichloromethane to isolate sphaerane bromoditerpenes, including
a previously uncharacterised, rare dactylomelane called sphaerodactylomelol, from the red alga
Sphaerococcus coronopifolius. The extracts were found to inhibit Escherichia coli, Pseudomonas aeruginosa,
Staphylococcus aureus, and Candida albicans. The greatest antibacterial was observed against
Staphylococcus aureus, with an IC50 value of 6.35 µM. Etahiri et al. [73] isolated bromosphaerone and
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12S-hydroxybromosphaerodiol from the same alga, Sphaerococcus coronopifolius. Bromosphaerone and
12S-hydroxybromosphaerodiol inhibited Staphylococcus aureus with MIC values of 0.104 µg/mL and
0.146 µg/mL respectively. It was proposed that the antibacterial activity of bromosphaerone was due
to its amphipathic structure of three polar alcohol groups, with non-polar aliphatic carbon and bromine
atoms on the opposite side of the molecule, enabling it to bind with bacterial cell membranes [13,73].
Xanthophylls, such as lutein and astaxanthin, are tetraterpene oxygen-containing compounds that
function as light harvesting pigments in plants and algae. They have been extensively documented
for their antioxidant activity, but are also effective against bacteria. Fucoxanthin is a xanthophyll
that occurs predominantly in brown algae (Phaeophyceae), diatoms (Bacillariophyceae), and at
lower concentrations in golden algae (Chrysophyceae) and Raphidophyceae [74–78]. Rajauria and
Abu-Ghannam [79] extracted fucoxanthin from the Irish brown seaweed Himanthalia elongata using
diethyl ether, n-hexane, and chloroform, and purified the crude extract using preparative TLC. In disc
diffusion assays, the purified extract was shown to be a potent inhibitor of Listeria monocytogenes,
with an inhibition zone of 10.27 mm at a concentration of 1 mg/mL (25 µg/disc). The extract was
98.4% as effective as an analytical grade fucoxanthin standard (inhibition zone 10.89 mm). Similarly,
Deyab and Abou-Dobara [80] extracted fucoxanthin from the brown seaweed Turbinaria triquetra,
the green Ulva lactuca, and the red Laurencia obtusa with chloroform and methanol. Extracts
were purified by silica column chromatography and identified by nuclear magnetic resonance
spectroscopy. Turbinaria triquetra showed the greatest bacterial inhibition, followed by Laurencia obtusa.
Ulva lactuca extracts had significantly lower antibacterial activity. Zones of inhibition for Escherichia coli,
Bacillus cereus, Bacillus subtilis, Klebsiella pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa
ranged from 4.0 mm to 7.0 mm (100 µg/mL extract/disc) and in the case of some Gram-negative
species, were equivalent to antibiotic standards.
3.6. Chrysophaentins
Plaza et al. [81] isolated eight compounds from the chrysophyte alga Chrysophaeum taylori
using hexane, chloroform, and methanol. The compounds were of a new chemical structural class
which they named chrysophaentins, which consisted of two polyhydroxylated, polyhalogenated
ω,ω1-diarylbutene units connected via two ether bonds. The chrysophaentins exerted powerful
inhibition in vitro of MRSA (MIC = 1.5 µg/mL), vancomycin-resistant Enterococcus faecium
(MIC = 2.9 µg/mL), and multidrug-resistant Staphylococcus aureus (MIC = 1.3 µg/mL). The
pharmacological mechanism of action of chrysophaentin is proposed to be unlike any existing
antibacterial agent. The functional groups within chrysophaentin act as enzyme inhibitors by binding
with guanosine triphosphatase in bacterial cells. This prevents the synthesis of a protein called FtsZ
(filamenting temperature-sensitive mutant Z), required for bacterial cell division. The development of
antibiotics and other antibacterial products from chrysophaentin continues to be an important area of
marine pharmacological investigation [82,83].
3.7. Lactones
Lactones are a chemical class of cyclic esters, which includes furanones. The Australian
red seaweed Delisea pulchra has been studied for its ability to remain free of surface bacterial
colonisation. Halogenated furanone extracts from Delisea pulchra have been used as effective surface
sanitisers in the prevention of Pseudomonas aeruginosa biofilm formation. This halogenated furanone
also inhibits quorum sensing mechanisms by interfering with bacterial inter-cell communication.
In order for bacteria to express specific genes during quorum sensing, signalling molecules
called acyl-homoserine lactones (AHLs) are required, as well as luminescence transcriptional
activator (LuxR) regulatory proteins. The furanone extract from Delisea pulchra competes with
AHL for the LuxR receptor site, thereby inhibiting virulence factor production and pathogenesis
in Pseudomonas aeruginosa [84,85]. Ren et al. [86] found a similar inhibition of quorum sensing
in Escherichia coli with a (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone extract from
Mar. Drugs 2016, 14, 81 7 of 23
Delisea pulchra. Quorum sensing in Escherichia coli was inhibited by blocking S-ribosylhomocysteine
lyase (LuxS) mediated AI-2 signalling. This influences genes and proteins involved in the normal
production of flagellar synthesis, motility, and chemotaxis in the bacterium. Manefield et al. [87]
identified another mechanism of inhibition exerted by a halogenated furanone from Delisea pulchra.
The bacterium, Erwinia carotovora, produces carbapenem as a virulence factor during quorum
sensing. A commercially available 4-bromo-5-(bromomethylene)-3-(11-hydroxybutyl)-2(5H)-furanone
was found to inhibit carbapenem production in Erwinia carotovora by disrupting the 3-oxo-C6-HSL
dependent expression of the carABCDEFGH operon. Castillo et al. [88] also reported that a commercially
produced furanone, similar to the Delisea pulchra extract, was effective against Gram-negative
Campylobacter jejuni. When combined with epigallocatechin gallate from green tea and a citric acid
extract, AI-2 activity, bacterial motility, and biofilm formation was significantly decreased.
Considering the efficacy of the Delisea pulchra extract against the Gram-negative
Pseudomonas aeruginosa and Escherichia coli in vitro, it is not unreasonable to propose that it could
also inhibit Gram-negative Campylobacter jejuni. Algal furanones and other lactones may have potential
as alternatives to synthetic surface sanitisers, and antibiotics. Campylobacter jejuni and Escherichia coli
are two of the leading causes of food poisoning worldwide, and have developed resistance to many
traditional antibiotics [89]. The demonstrated ability of algal furanone extracts to prevent biofilm
formation may be useful in the treatment of Pseudomonas aeruginosa infection, which is characterised
by the formation of a mucoid film in the lungs of cystic fibrosis sufferers. Pseudomonas aeruginosa is
also an increasing risk to the immunocompromised, such as premature babies, and long-term hospital
patients [90].
Algal polysaccharides, fatty acids, peptides, proteins, phlorotannins, terpenes, chrysophaentins,
and lactones make good candidates for antibiotics, and incorporation into human food products for
safety and preservation as they are edible, non-toxic, and inexpensive. Further research, including
in vivo toxicology studies, into these antibacterial extracts could produce very useful food preservation
and pharmaceutical products.
4. Effect of Extraction Methodology on Antibacterial Potency
4.1. Environmental Influences
A number of factors influence the efficacy of algal antibacterial compounds and should be taken
into consideration when comparing extraction methods. Natural factors such as ontogenetic and
environmental influences, seasonal variations, ocean temperature, salinity, and pollutants have a
profound influence on the content and potency of algal bioactives. For example, the alginate, mannitol,
laminarin, and polyphenolic contents of Laminaria digitata, Laminaria hyperborea, Saccharina latissima,
and Alaria esculenta are known to vary significantly throughout the year. In Laminaria species sampled
off the west Scottish coast, polyphenols have been reported to accumulate with the on-set of the growth
phase between May and July and reach their lowest levels in October [91,92]. Bioactive compounds
are present at fluctuating concentrations during different stages of the algal life cycle. In addition,
distribution varies in each discrete part of the thallus, i.e., holdfast, blade, and stipe [93]. Sampling of
each section of the thallus, and analysis of the same species at different points throughout the year
provides more accuracy.
4.2. Extraction Method and Solvent
The means by which algal antibacterial compounds are extracted from raw biomass impacts
their pharmacological efficacy. The extraction method and solvent choice influence the physical and
chemical properties of the extract. Various extraction protocols for the recovery of antibacterials from
marine algae have been reported. Some involve freeze drying, Soxhlet extraction, and the use of organic
solvents, enzymes, or bacterial fermentation. Maceration, often with liquid nitrogen, is generally
required for algae, in order to release cell components from the tough, polysaccharide-rich thallus of
Mar. Drugs 2016, 14, 81 8 of 23
seaweeds, and the silica-bound cell walls of microalgal diatoms. This exposes them to the extraction
solvent. Protocols employ different extraction temperatures, times, pH ranges, and concentrations. All
these variables influence the efficacy of the final antibacterial product.
4.2.1. Solvent Polarity
The polarity of the extraction solvent profoundly affects the manner in which the extract will
interact with functional groups on bacterial surfaces. For example, depending on the polarity of the
solvent used, functional groups extracted may be polar hydrophilic or non-polar lipophilic. This
influences the ability of the algal extract to act upon the cell membrane and other components of
Gram-positive and Gram-negative bacteria. In a recent study, Moorthi and Balasubramanian [94]
compared acetone, methanol, and chloroform Soxhlet extraction in the evaluation of the antibacterial
efficacy of the brown seaweed Sargassum muticum harvested in India. Disc diffusion assays were
used to measure its efficacy against foodborne human pathogenic bacteria Salmonella paratyphi,
Staphylococcus epidermis, Enterobacter aerogenus, Klebsiella pneumoniae, Shigella fleschneri, Proteus vulgaris,
MRSA, and Salmonella typhimurium. At concentrations of 30 µL/mL, acetone extracts were significantly
more potent than chloroform or methanol extracts against Salmonella paratyphi, Salmonella typhimurium,
Staphylococcus aureus and Shigella fleschneri. Chemical analysis of the Sargassum muticum acetone
extracts showed the presence of tannins. The effectiveness of acetone for the extraction of antibacterials
from Sargassum wightii and Caulerpa scalpelliformis has previously been reported, and attributed to the
ability of polar acetone to bind with the hydrophilic phlorotannins in seaweed which, as discussed,
have potent antibacterial activity [95,96].
Since lipophilic compounds in algae also have antibacterial activity, non-polar solvents such
as hexane, or supercritical carbon dioxide are also commonly employed. Mendiola et al. [97] used
supercritical CO2 for 60 min, at 40 ˝C, 400 atm to extract lipids from the microalga Chaetoceros muelleri.
The free fatty acids extracted significantly inhibited Escherichia coli and Staphylococcus aureus growth.
Unlike most organic solvents, supercritical CO2 has the benefit of being environmentally friendly
since it is gaseous at room temperature and pressure, leaving no trace in the extracts. Solvent-free
antibacterial extracts such as these have potential as food preservation ingredients.
Extraction yield is also impacted by solvent choice, which in turn affects efficacy of the
antibacterial. Rajauria et al. [98] reported different combinations of methanol and water (20%–80%)
to have a significant effect on the yield of antimicrobial and antioxidant polyphenolic compounds
from the Irish brown seaweed Himanthalia elongata. The greatest yield (6.8%) was achieved using
60% methanol, compared to the lowest yield (1.2%) using 100% methanol. Disc diffusion and broth
dilution tests showed the 60% methanol extract at a concentration of 60 mg/mL to be the most
potent inhibitor of Gram-positive Listeria monocytogenes and Enterococcus faecalis; and Gram-negative
Pseudomonas aeruginosa and Salmonella abony. The Himanthalia elongata extract had greater, or at
least equal, zones of inhibition against all bacteria compared to the synthetic food preservatives
sodium nitrite and sodium benzoate. Cox et al. [5] also found that the antibacterial activity of
polyphenolic seaweed extracts was solvent-dependent. Methanol was determined to be the most
effective for the brown seaweeds Himanthalia elongata, Laminaria digitata, and Saccharina latissima;
while acetone and ethanol were more effective for the green species Enteromorpha spirulina; and
the red species Palmaria palmata and Chondrus crispus. Antibacterial activity was tested on food
spoilage (Enterococcus faecalis and Pseudomonas aeruginosa) and pathogenic (Listeria monocytogenes
and Salmonella abony) bacteria using the microwell plate method. Using methanol only, green and
red seaweed extracts had significantly lower antibacterial activity than the brown species, however
their potency increased significantly when ethanol and acetone were used as solvents. In the case
of Chondrus crispus, Enterococcus faecalis inhibition increased from 39% to 100% using ethanol and
acetone. Methanol extracts of Himanthalia elongata showed 100% inhibition of Listeria monocytogenes,
Enterococcus faecalis, and Salmonella abony, which was, on average, 4.34% greater than that of sodium
nitrite and sodium benzoate. Laminaria digitata also inhibited Listeria monocytogenes by 100%.
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Since the structure and solubility of algal antibacterial compounds varies so greatly, using a series
of solvents with an incremental range of polarities and concentrations would ensure the extraction of
polar and non-polar fractions.
4.2.2. Food Grade Solvents
Solvent choice also influences potential applications of algal antibacterial extracts in terms of
human and animal consumption. Many organic solvents such as methanol and dimethyl sulphoxide
(DMSO) produce high extraction yields, but leave toxic levels of residue. A number of food-grade
solvents have been approved for use in the extraction of bioactives for consumption. Since 1966, The
Food Chemicals Codex has been recognised internationally as the authority for agreed standards in
ingredients, preservatives, extraction solvents, enzymes, and bacteria that are permissible for food
use [99]. The European Union also issues Directives on food-approved solvent systems and residual
limits, which are administered by the European Food Safety Authority. For example, Commission
Directive 2010/67/EU sets out the maximum acceptable residues for acetone, hexane, and ethanolic
extracts of rosemary. The acceptable concentrations are given as not more than 500 mg/kg acetone;
25 mg/kg hexane; and 500 mg/kg ethanol. The Directive also recommends further purification of the
extract with active carbon and/or molecular distillation [100]. Alternatively, solvents that are generally
recognised as safe (GRAS) under Sections 201 and 409 of the U.S. Federal Food, Drug, and Cosmetic Act
can be utilised, with no issues of toxicity [101]. For example, in a recent study, Boisvert et al. [102] used
pressurised liquid extraction with approved, food-grade ethanol to extract high yields of antibacterial
and antioxidant-rich compounds from three species of seaweed, Ascophyllum nodosum, Ulva lactuca, and
Saccharina longicruris, from the St Lawrence Estuary, Canada. Antibacterial activity was tested against
three food spoilage bacteria, Micrococcus luteus, Escherichia coli, and Brochothrix thermosphacta, using the
microtiter method. The greatest inhibition of Escherichia coli (69.5%), Micrococcus luteus (61.4%), and
Brochothrix thermosphacta (21.4%) was exerted by Ulva lactuca extracts at a concentration of 500 µg/mL.
The greater potency of the Ulva lactuca compared to the other species was thought to be due to a
higher mineral concentration of metals such as copper, zinc, silver and mercury, which have innate
antibacterial activity. This choice of food grade solvent and green extraction method exemplifies some
of the approaches that can be used in the development of safe algal antibacterials.
4.3. Novel Extraction Technologies
Aside from traditional solid-liquid extraction, a number of novel technologies have been
developed with the aim of improving yields, minimising damage to analytes, reducing solvent waste,
and conserving energy and time. These can have significant effects on the yield and potency of algal
antibacterial extracts. Technologies include extraction assisted by microwaves, pulsed electric fields,
pressurised solvents, supercritical fluids, ultrasound, and enzymes [103]. The latter three technologies
are most applicable to algal extraction, and are outlined here.
4.3.1. Supercritical Fluid Extraction
When brought to a pressure and temperature above its critical point, a fluid or gas becomes
supercritical. While in this state, it possesses the physical properties of a gas and can effuse through
solids; but can also act as a liquid solvent [104]. These properties are highly useful for the extraction
of bioactive compounds from organic tissues. Carbon dioxide is most commonly used for food
and pharmaceutical applications as it completely dissipates after extraction at room temperature.
Coffee, for example, is decaffeinated using supercritical CO2. As discussed in Section 4.2.1,
Mendiola et al. [97] used CO2 supercritical fluid extraction to isolate lipids with antibacterial activity
from the microalga Chaetoceros muelleri. A highly significant increase in antibacterial activity was
reported using this method in comparison to traditional methodologies. To compare the efficiency of
their method, a liquid-liquid DMSO flask extraction of raw Chaetoceros muelleri was prepared. A broth
microdilution method was used to evaluate the MIC value of each extract against Escherichia coli and
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Staphylococcus aureus. The supercritical fluid extractions exerted three times more bacterial inhibition
than the DMSO extract. Despite the increased energy demands of supercritical fluid extraction, it offers
a green chemical alternative to solvent based methods for antibacterial agents destined for food and
pharmaceutical uses.
4.3.2. Ultrasound Assisted Extraction
Ultrasound or ultrasonic technology uses high intensity sound waves to penetrate a liquid,
producing alternating high and low pressure cycles. During low-pressure, high-intensity ultrasonic
waves create tiny vacuum bubbles. When the high-pressure cycle begins they implode, or cavitate,
releasing liquid jets at extremely high velocity. This high shear force ruptures the cells of organic
tissue, releasing their contents [105]. This has a positive effect on the yield and potency of bioactive
extracts. Kadam et al. [48] compared the efficiency of ultrasound assisted and solid-liquid flask
extraction of laminarin from the Irish brown seaweeds Laminaria hyperborea and Ascophyllum nodosum.
Two solvents were compared for both extraction methods; water, and 0.1 M hydrochloric acid.
As discussed, laminarin is an algal polysaccharide with antibacterial activity. The percentage yield
of laminarin was significantly greater in both water and HCl ultrasound assisted extracts for both
seaweeds. Laminaria hyperborea ultrasound/HCl yield was 6.240%, compared to only 3.254% from the
flask/HCl extraction. The ultrasound assisted yield was 47.85% greater. Similarly, Ascophyllum nodosum
ultrasound/HCl yield was 5.822%, compared to 4.304% from the flask/HCl extraction. The ultrasound
assisted yield was 26.08% greater. The ultrasound assisted water extracts of Laminaria hyperborea
(5.975%) and Ascophyllum nodosum (5.290%) were also greater than the water flask extractions (4.362%
and 4.599% respectively). Aside from the substantial increase in laminarin yields, the ultrasound
process was also far more energy efficient, requiring only 15 min in a 750 W ultrasonic processor, at an
amplitude level of 60%; compared to 2.5 h at 70 ˝C for solid-liquid extraction. Ultrasound assisted
extraction is a suitable technology for deriving antibacterial compounds from algae, as it obviates the
need for high temperatures, toxic solvents, and prolonged extraction times. It also fractionates the
hardy, complex cell walls of algae [106].
4.3.3. Enzyme Assisted Extraction
Extraction through the application of enzymes, such as cellulases, has the potential to increase
the yield and safety of algal antibacterials. The presence of branched, sulphated, or complex
polysaccharides, such as alginate and laminarin, in algal cell walls limits the efficiency of classical
extraction methods [11,107]. Food-grade digestive enzymes, such as proteases and carbohydrases,
could aid in the degradation of cell wall matrices, thus releasing cell components. To date, little has been
published on the use of enzymes for the extraction of antibacterial compounds from algae specifically.
However, in the extraction of algal bioactives such as antioxidants, polysaccharides, carotenoids and
polyphenols, the use of enzymes has shown significant potential as a viable alternative, or addition to,
pure solvent methods [108–111]. Since antioxidants, polysaccharides, carotenoids, and polyphenols,
have proven antibacterial activity, it is expected that their enzymatic extracts could also be used
to inhibit bacteria. For example, there is an implied correlation between antioxidant activity and
antibacterial activity, since algal antioxidant compounds, like fucoxanthin, have been shown to be
potent antibacterials. Enzyme assisted extraction could potentially increase extraction yields of algal
antibacterials. Bioactive yields from terrestrial plants, such as the carotenoid lycopene from tomatoes,
have been increased by enzymolysis. Zuorro et al. [112] reported an eighteen fold increase in lycopene
yield from tomato processing waste in pectinase and cellulase pre-treated samples, compared to hexane
extraction alone. In the extraction of fucoxanthin from Undaria pinnatifida, Billakanti et al. [113] reported
a 9.3% increase in fucoxanthin yield using an enzyme pre-treatment of alginate lyase, followed by
dimethyl ether and ethanol extraction, compared to non-enzyme treated. Optimum parameters for
alginate lyase pre-treatment were 37 ˝C, for 2 h, pH 6.2, 5% (w/v) solids, with 0.05 wt % enzyme.
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Each of these novel extraction technologies has the potential to replace or reduce solvent driven
methods for the recovery of algal antibacterial compounds. Initial set-up costs may be more costly
than traditional solvents, but there are several long-term advantages. Supercritical fluid extraction,
ultrasound assisted extraction, and enzyme-assisted extraction are non-toxic, environmentally
harmless, and in many cases, increase product yields.
5. Marine vs. Terrestrial Antibacterials
Both marine and terrestrial organisms produce secondary metabolites that protect them from
bacterial infection. It is serendipitous that these metabolites also have activity against many pathogenic
bacteria which affect humans and animals. Marine algal extracts, such as those discussed in this article,
along with terrestrial plant extracts like lavender and tea tree oil, have been used throughout history
as natural antimicrobials and as medicines in pharmacognosy. Since marine and terrestrial organisms
face vastly different environmental challenges, the structural features and pharmacological activity of
their metabolites differ greatly [114]. It has been proposed that some marine antibacterial compounds,
from organisms such as algae, have greater antibacterial efficacy than those from terrestrial sources.
This has been attributed to the greater bacterial cell numbers in seawater compared to air, and the need
for sessile organisms to prevent surface biofouling in the ocean [115].
In study by Wang et al. [32] the bacteriostatic and bactericidal activity of methanol extracted
phlorotannins from Ascophyllum nodosum harvested in Nova Scotia was compared with hydrolysable
and condensed tannins from two trees, Quebracho (Schinopsis balansaei) and Chinese sumac
(Rhus semialata). Four strains of Escherichia coli resistant to ampicillin, kanamycin, and nalidixic
acid were used to measure inhibition at OD600. At a concentration of only 25 µg/mL, the phlorotannins
from Ascophyllum nodosum exerted bacteriostatic effects on three of the strains for up to 24 h, after
which time two strains resumed growth. Phlorotannins were fully bactericidal to Escherichia coli at
50 µg/mL in the case of two strains, and at 100 µg/mL in the case of the other two. The hydrolysable
and condensed tannins from the tree extracts were compared at the same concentrations against two of
the Escherichia coli strains. However, condensed tannins did not exert a bactericidal effect against either
of the two strains, and only had bacteriostatic activity against one strain for 6 h. Hydrolysable tannins
had no bactericidal or bacteriostatic activity against either of the two strains. The treated and untreated
Escherichia coli cells were examined by transmission electron microscopy. The membrane structure of
the untreated cells was smooth and even. The action of the tannins was apparent on the cell walls of
treated samples, particularly in the case of Ascophyllum nodosum, where disorganised structures and
electron-dense precipitated deposits were visible. The significant differences demonstrated between the
marine algal and terrestrial tannins may be attributed to their chemical structure. Although all tannins
are composed of cyclic phloroglucinol groups, terrestrial hydrolysable and condensed tannins have a
maximum of three rings, whereas algal phlorotannins have up to eight. This means phlorotannins have
more hydroxyl groups, enabling them to produce more hydrogen peroxide under aerobic conditions.
Hydrogen peroxide is toxic to bacteria [11]. Hydroxyl groups can also form hydrogen bonds with
proteins on the bacterial surface, further denaturing the cell.
Although this study by Wang et al. [32] clearly illustrates the comparative activity of marine algal
vs. terrestrial antibacterial compounds, further comparisons and research into this area with a wide
range of chemical classes is required.
6. Inhibition of Foodborne Pathogenic and Spoilage Bacteria in Food Production
Incidents of food poisoning have increased dramatically in the last few decades due to changes in
consumer eating habits, and the growing resistance of spoilage and pathogenic foodborne bacteria to
antibacterial agents [116]. With increasing pressure from the public, food manufacturers are moving
away from traditionally used synthetic preservatives, and high levels of salt towards naturally derived
alternatives. These natural antimicrobials derived from terrestrial plants and marine algae offer
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shelf-life extension and increased safety from bacteria that cause food poisoning, without the side
effects associated with many synthetic preservatives or high salt intake.
Gupta et al. [117] evaluated the antibacterial activity of three edible Irish brown seaweeds,
Himanthalia elongata, Saccharina latissima, and Laminaria digitata in raw and heat processed (95 ˝C) form.
Their activity was tested against pathogens which commonly cause problems in the food industry,
Listeria monocytogenes, Salmonella abony, Enterococcus faecalis, and Pseudomonas aeruginosa. In microtiter
assays, methanol extracts of raw Himanthalia elongata (60 mg/mL) inhibited Listeria monocytogenes by
98.7%, compared to 96.5% inhibition by the synthetic preservative standard sodium benzoate, and
sodium nitrite (96.2%). Raw Himanthalia elongata was also more potent than the standards against
Enterococcus faecalis and Pseudomonas aeruginosa. Raw Saccharina latissima extracts were almost as potent
against all four bacteria, followed by Laminaria digitata. Heat treatment significantly reduced the
antibacterial activity of all seaweeds. These raw seaweed extracts may be useful for incorporation
into products such as raw meats and fish, as they would exert their bacterial inhibition during the
uncooked, cold storage phase, before inactivation by heat, at which stage the product would be
consumed. A recent study by Dussault et al. [118] explored the potential of developing several
commonly consumed Pacific Island seaweeds into food preservation agents. In broth dilution assays,
methanol extracts of the brown species, Padina and Dictyota, were found to inhibit the growth of
Gram-positive foodborne pathogens Listeria monocytogenes, Bacillus cereus, and Staphylococcus aureus
at low concentrations (ď500 µg/mL). However, the extracts had no activity against Gram-negative
species, possibly due to the inability of the moderate to low polarity, hydrophobic extracts to breach
the hydrophilic lipopolysaccharide, Gram-negative bacterial membrane. The extracts are not known
to have any toxicity at the concentrations used, making them good candidates for incorporation into
foods prone to Gram-positive bacterial growth.
6.1. Active Food Packaging Applications
Marine algal compounds also have potential for use as components of antibacterial films made
from biodegradable materials which are widely used in active food packaging applications. Several
edible food coatings from alginates and carrageenan have been developed [119,120]. Olaimat et al. [121]
reported a significant reduction in viable Campylobacter jejuni numbers on vacuum-packed raw chicken
breasts using a carrageenan and chitosan based coating containing heat-treated oriental mustard extract.
Although the mustard contained a natural antibacterial compound, allyl isothiocyanate, chicken treated
with a mustard-only extract coating did not have significantly lower Campylobacter jejuni numbers
than the untreated control-coated chicken after 21 days storage. The carrageenan-chitosan-mustard
coated samples reduced Campylobacter jejuni numbers by up to 2.78 log10 CFU/g more than the
control coating at 21 days. Lactic acid bacterial growth was also reduced. Methods of controlling
Campylobacter jejuni would be highly beneficial to poultry based food producers. Gram-negative,
microaerophilic Campylobacter jejuni is one of the most frequent causes of foodborne illness worldwide,
with hens being the main source in most disease cases [122].
Rodríguez-Martínez et al. [123] formulated a new, active biodegradable film based on polylactic
acid and brown seaweed. An extrusion process was used to incorporate 8% dried Fucus spiralis seaweed
extract and 0.5% natural sorbic acid into a polylactic acid based biodegradable film. The migration
values of the film components into food simulants were found to be generally within the maximum
acceptable EU limit. It was concluded that the film was suitable for further development as a packaged
food protectant and for shelf-life extension. Fucus spiralis was selected because it showed the greatest
inhibition in disc diffusion assays of the foodborne bacteria Staphylococcus aureus, Bacillus cereus,
Bacillus subtilis, Pseudomonas fluorescens, Escherichia coli, Klebsiella pneumoniae, Aeromonas hydrophila,
Vibrio alginolyticus and Vibrio parahaemolyticus, when compared to other seaweed genera, Ascophyllum,
Ulva, Bifurcaria, and Gracilaria. A concentration of only 10 µg/mL of Fucus spiralis was required to exert
zones of inhibition up to 15 mm (for Bacillus subtilis). Although sorbic acid has antimicrobial properties
against fungi and bacteria, the addition of Fucus spiralis extract reduces the amount required, and
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broadens the scope of antibacterial activity. Sorbic acid was first isolated from mountain ash berries,
and has antimicrobial action mainly against yeasts and moulds, but is selective against bacteria [124].
It can also be detected as an acrid taste by some consumers. The addition of small amounts of dried
seaweeds, or antibacterial extracts of marine algal compounds to active food-films could minimise
the volume of traditional preservatives required. This could reduce costs and bring concomitant
nutritional benefits.
6.2. Animal Feed Supplementation and Aquaculture
Antibacterial algal extracts such as laminarin and fucoidan can also be incorporated into
animal feed to improve the safety and nutritional profile of animal products destined for human
consumption [9,125,126]. Moroney et al. [127] reported an enhancement of pork quality in meat
from pigs fed extracts of Laminaria digitata containing laminarin and fucoidan for three weeks prior
to slaughter. Animals were fed either 450 mg or 900 mg laminarin and fucoidan per kg feed.
In both cases, pork meat was found to have an improved fatty acid profile without loss of lipid
stability. Saturated fatty acid content was significantly lowered and lipid oxidation was reduced.
Aquacultural food products can be a source of foodborne pathogenic and spoilage bacteria. Vibrio
genera are a common source of foodborne illness in fish products. Seaweeds have been shown to
have antibacterial properties against many species that infect farmed fish, which in turn reduces the
occurrence of pathogenic bacteria in the final food product [128]. Roohi Fatima et al. [129] enhanced
the microbial safety of farmed Mozambique tilapia fish by adding an antibacterial methanol extract of
the red seaweed, Portieria hornemannii, to housing tanks (1 part per trillion per litre). The instances
of Vibrio parahaemolyticus infection amongst the fish were significantly decreased compared to the
untreated group. Histology tests also showed the same significant decrease of Vibrio parahaemolyticus
in muscle tissue.
6.3. Consumer Acceptance
Preservatives are necessary to ensure the safety of perishable foods such as meat, fish, and ready
to eat products. Consumer trends are influencing the use and development of natural alternatives
to synthetic preservatives such as sodium benzoate and sodium nitrite which have associated health
side-effects. A number of antibacterial extracts from terrestrial plants have already gained consumer
acceptance. Plant extracts with pharmacological activity such as linalool, thymol, and camphor
have been used successfully as preservatives in many commercial products [130]. Existing consumer
acceptance of preservatives from plants such as citrus fruits, thyme, rosemary, basil, lemon balm, and
marjoram may aid the introduction of marine algal antibacterials to mainstream foods. However,
organoleptic impacts must be assessed with sensory trials as well as any interactions with food
matrices. The antibacterial activity demonstrated by marine algal extracts in vitro and in pilot food
studies provides a basis for further research and product development in this area. The high efficiency
of bacterial inhibition in comparison to industry standard preservatives discussed in this review
makes algal extracts excellent candidates for incorporation into foods. Seaweeds are also non-toxic,
inexpensive, and contain minerals, vitamins, and proteins.
7. Synergistic Effects
Synergism can occur between two or more compounds with pharmacological activity, such as
orthodox drugs or natural products. This can produce a negative effect in the form of contraindication,
where active substances exert a more potent effect when combined than they would if used individually.
However, controlled synergistic interaction allows lower doses of the active substances to be used,
which can result in fewer side effects [131]. Some marine algal derivatives have been reported
to enhance the pharmacological activity of drugs used to combat human pathogenic bacteria.
Lee et al. [132] examined the synergistic effect of combining the sulphated polysaccharide fucoidan
from brown seaweeds with antibiotics to inhibit cariogenic and periodontopathogenic bacteria which
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cause dental infections. The fucoidan (analytical grade) was combined with either ampicillin or
gentamicin, two common antibiotics. The minimum inhibitory and bactericidal concentrations of the
fucoidan/antibiotic complexes were measured against Streptococcus mutans, Streptococcus sanguinis,
Streptococcus sobrinus, Streptococcus ratti, Streptococcus criceti, Streptococcus anginosus, Streptococcus
gordonii, Actinobacillus actinomycetemcomitans, Fusobacterium nucleatum, Prevotella intermedia, and
Porphylomonas gingivalis. The results were highly significant. The MIC and minimum bactericidal
concentration (MBC) values were reduced on average by a factor of four. Therefore, only a quarter
of the ampicillin or gentamicin dose was required to kill all species of bacteria when combined with
fucoidan. The study concluded that the inherent antibacterial properties of fucoidan, and its ability to
affect bacterial cell wall synthesis, was responsible for the synergistic effect observed. The formation
of bacterial biofilms in the mouth commonly leads to dental cavities, gingivitis, and periodontitis.
If antibiotics must be prescribed for a patient, a significant reduction in the required dose such as
observed in the above study would be beneficial for the individual’s gut health and immune system.
He et al. [133] also reported a synergistic effect using marine algal derivatives and antibiotics.
In the study, the antibiotic azithromycin was combined with a marine alginate-derived oligosaccharide
(ADO). MIC values required to inhibit wild-type resistant Pseudomonas aeruginosa were measured for
azithromycin, and for the azithromycin/ADO complex. The MIC value was significantly reduced
by a factor of 2.8 by the addition of the ADO. The MIC for azithromycin alone was 152.6 µg/mL.
This was reduced to 54.2 µg/mL using the azithromycin/ADO complex. This synergistic effect was
attributed to the ability of charged groups in ADO to interact with anionic/cationic groups on the
bacterial cell surface, forming a layer that blocks the transport of essential materials into the cell.
In addition, G subunits of ADO chelate cations such as Ca2+ thereby acting as an antagonist toward
voltage-operated calcium channels. Quorum sensing-controlled virulence factors (elastase B and
pyocyanin) and biofilm development was also suppressed by the addition of ADO, allowing the
reduced level of azithromycin to act more effectively. Synergism such as this between marine algal
derivatives and traditional antibiotics continues to be developed as an innovative approach to combat
antibiotic-resistant bacteria.
8. Biotechnological Potential of Marine Algae
Algal biotechnology entails the use of micro or macroalgae to produce or transform useful
products for specific functions [134]. This may involve manipulating the algal cells into overexpressing
a secondary metabolite, or some compound of pharmacological or industrial interest by altering
environmental parameters such as temperature, pH, or food availability. Using an organism as a cell
factory in this manner has been successfully applied to bacteria, plants, and many other organisms
for decades. The microalga, Dunaliella salina, for example, naturally produces high concentrations of
β-carotene to survive its hypersaline environment. Controlling salinity in bioprocessors containing
Dunaliella salina forces the alga to increase β-carotene synthesis which can then be harvested for
human use [135]. Biotechnology may also involve transgenesis, which is the introduction of a foreign
(trans) gene into a cell in order for the organism to produce a new, inheritable trait such as the
synthesis of a new biomolecule or expression product. Genes can be introduced to algal cells to
produce biomolecules with antibacterial activity such as phlorotannins or terpenes. A recent study by
Guzmán-Zapata et al. [136] described the successful, inheritable genetic transformation of chloroplasts
in the green microalga Chlamydomonas reinhardtii to produce useful recombinant proteins.
In addition, marine algal antibacterial compounds, such as polysaccharides, are currently being
studied for their nanobiotechnological applications in drug delivery, wound dressing, cancer therapy,
and tissue engineering. Their biocompatibility, biodegradability, and lack of toxicity makes them
promising leads in this area [137].
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Omics Studies
More recently developed biotechnological tools such as transcriptomics, nutrigenomics,
metabolomics, proteomics, and metagenomic profiling are now being applied to algae, and will aid in
the understanding of their genome and their pharmacological interactions with bacteria [138–140]. For
example, transcriptomic studies on marine algae provide useful genomic data that may be used to
identify species with antibiotic potential. The transcriptome is the set of all messenger RNA molecules
in one cell or population of cells. Sequencing the transcriptome allows for the comparison and
identification of genes that are differentially expressed in discrete cell populations, or in response
to different environmental factors [141,142]. Hovde et al. [143] sequenced the transcriptome of the
microalga, Chrysochromulina tobin at seven time points over a 24h light/dark circadian cycle. Significant
differences in gene expression were seen at different time points for processes such as fatty acid
synthesis and modification. Amongst the genes identified, those involved in defence of the alga
were found to encode potential antibiotics, antibiotic extrusion proteins, and novel antibacterial
peptides. The transcriptomic sequencing also revealed the first algal polyketide synthase-non ribosomal
peptide synthetase. The findings may provide potential routes for the synthesis of therapeutics
and useful novel metabolites. Algal compounds with potential pharmacological activities were
also reported by de Oliveira et al. [144] from the transcriptomic sequencing of the red seaweed,
Laurencia dendroidea, and its microbiome. Six specimens of Laurencia dendroidea and their transcriptomes
were sequenced from three Rio de Janeiro coastal locations. Genetic sequences related to terpene
biosynthesis and the mevalonate-independent pathway were identified. Understanding the genomic
mechanisms of these pharmacologically active secondary metabolites provides a potential for novel
biotechnological applications.
9. Chemical Synthesis
A number of challenges exist for the development of marine algal antibacterial products, such
as supply, sourcing, and ecological issues. This is particularly applicable to compounds with
pharmacological activity that are present in miniscule quantities within a microalga or seaweed.
Mariculture of selected species is an option, however it is labour intensive and would still necessitate
the production of large volumes of biomass. The marine environment in which an alga of interest
grows can be very inaccessible, and incur huge harvesting risks and costs [145]. It would also be
ecologically damaging to remove substantial quantities of any species from their natural marine,
or other, environment. Total chemical synthesis of pharmacologically activity natural compounds
offers a solution. Chemical synthesis of rare natural drug compounds has been used successfully for
many terrestrial plants. An example is the synthetic anticancer drug paclitaxel, which was developed
from taxol, a naturally occurring extract of Pacific yew (Taxus brevifolia) bark. This rare tree would
have become extinct if harvested continuously. However, its chemical structure was elucidated,
with the synthetic form exerting an identical mechanism of action on cancer cells. Several natural
marine products have been successfully synthesised, such as the analgesic ziconotide (Prialt). This
is the synthetic form of ω-conotoxin peptide, originally derived from a defence toxin produced
by the marine Cone Snail. Urosa et al. [146] synthesised Luffarin I, a sesterterpenolide, originally
found in the sea sponge, Luffariella geometrica, using commercially available sclareol. The chemical
synthesis of marine algal antibacterial compounds is now a growing area of research. The genetic
mechanism of terpene biosynthesis in the red seaweed, Laurencia dendroidea, was recently elucidated by
de Oliveira et al. [147]. This genus of seaweed produces halogenated terpenoids and acetogenins which
have important biotechnological applications, however, little was known about the genes that code
for these compounds. The study identified forty one genes involved in the biosynthesis of terpenoid
precursors and terpene synthases. The findings pave the way for the chemical synthesis of terpenes
with antibacterial and other applications.
Total chemical synthesis of bioactive compounds such as algal antibacterials has many advantages
aside from increased supply. It protects the marine environment from over-harvesting and allows for
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research into chemical structure-activity relationships and drug lead optimisation of the antibacterial.
Modifications of the structure, such as the addition of polar or non-polar functional groups, can lead to
increased efficacy at the target site, reduced side effects, and improved physiochemical and metabolic
properties [148,149].
10. Conclusions
Drug-resistant bacteria pose an increasing challenge to global health. The European Centre for
Disease Prevention and Control estimates that antimicrobial resistance results in over 25,000 deaths
across Europe each year [150]. Antibacterial agents with pharmacological mechanisms of action that
differ to those of traditional antibiotics must be developed to stem the rise in global bacterial resistance.
The in vitro studies discussed in this review show promise for similar in vivo efficacy. Some hurdles
exist in marine product development, such as supply issues, determination of the efficacy target, and
full chemical synthesis. As with all areas of drug discovery, extensive clinical trials will be required
to determine the in vivo fate of marine antibacterial extracts on mammalian cells in terms of first
pass metabolism and possible toxicity. The marine environment is home to an immense taxonomic
diversity that has remained relatively unexplored in drug discovery by terrestrial standards. In order
to overcome the challenges to marine natural product development a multi-disciplinary strategy can
be adapted which utilises nascent technologies and tools for developing novel antimicrobial agents.
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